Pharmasset Reports Fiscal First Quarter 2009 Financial Results
... 30, 2009, Pharmasset filed an IND for PSI-7851, a nucleotide inhibitor of HCV, with the FDA and expects to ... filing an IND for PSI-7851, our second generation nucleotide for HCV and, strengthening our balance sheet by ... phase 1 studies with its second generation nucleotide inhibitor for HCV, PSI-7851 in the first quarter ...Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
... healthy volunteer in the phase 1 trial with PSI-7851, a second generation nucleotide inhibitor of HCV. "Our HCV pipeline continues to make ... collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the ...SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM)
... while lowering cost. These benefits are achieved through LaserGen's nucleotide chemistry by attaching a special terminating group directly to the base, ... cleavage, however, Lightning Terminators(TM) restore the incorporated nucleotide back to its natural state. This distinguishes the LaserGen chemistry from ...Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug
... drug for a kidney target, ISIS-SGLT2Rx is also unique due to its 12 nucleotide length rather than the more typical 18 - 21 nucleotide sequences that comprise Isis' other drugs, an attribute that reduces the ...Pharmasset to Present at Canaccord Adams Conference
... being conducted through a strategic collaboration with Roche. Our other clinical stage candidates are PSI-7851, an unpartnered, next generation HCV nucleotide analog which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV, which has completed a Phase 2 clinical trial. ...SEQUENOM Announces Launch of MassARRAY Compact 96 System
... changes to assays and biomarkers throughout the validation process. MassARRAY technology supports key genomic applications, including single nucleotide polymorphism (SNP) genotyping, quantitative gene expression, and copy number variation (CNV) analysis, providing a multi-faceted view of a ...Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
... that it had successfully completed a proof-of-concept study of its lead HCV antiviral development program, IDX184, a novel once-daily liver-targeted nucleotide prodrug. This double-blind, placebo-controlled, monotherapy, dose-escalation study in HCV genotype-1-infected patients evaluated the safety and ...Beyond associations: Colorectal cancer culprit found
... in this search by the genome-wide association study (GWAS), a technique that scans the genome for known common genetic variants, also known as single nucleotide polymorphisms, or "SNPs," that are more prevalent in patients with a specific disease. However, a SNP associated with a disease is not necessarily ...California Grants SeqWright License to Operate as a Clinical Laboratory
... today that it has been granted a California clinical laboratory license. This license enables SeqWright to utilize its DNA sequencing and Single nucleotide Polymorphism (SNP) Genotyping expertise in order to provide genetic tests to California residents and represents a significant step forward in the ...Discovery of a new retinal gene involved in childhood blindness
... detailed screen are then subjected to a second DNA chip, this one to identify significant stretches of homozygosity in SNP markers. SNPs are single nucleotide repeats, which are natural variations in the human genome. These homozygous regions may contain new genes and are carefully probed based on ...Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
... million in development, regulatory and sales milestones. During 2008, Idenix completed a phase I, healthy volunteer study of IDX184, its lead nucleotide polymerase inhibitor for the treatment of hepatitis C, and advanced the drug candidate into proof-of-concept testing in treatment-naive HCV-infected ...23andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases
... for genome-wide association studies and has the unique capability to include custom markers. This feature enabled 23andMe to select SNPs (single nucleotide polymorphisms), or variants that provide coverage of genes associated with drug response, information that is proving to be critical for the ...Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
... amended to also evaluate a 100 mg/day dose. -- Idenix has submitted an investigational new drug (IND) application for IDX184, a once-daily, oral nucleotide prodrug candidate for the treatment of chronic hepatitis C, to the United States Food and Drug Administration (FDA) and has initiated a phase I ...DNA Study Unlocks Mystery to Diverse Traits in Dogs
... Kennels in Gilroy, California and Mars' Waltham Center for Pet Nutrition in the United Kingdom, studied simple genetic markers known as Single nucleotide Polymorphisms, or SNPs, to find places in the dog genome that correlate with breed traits. Because many traits are "stereotyped" -- or fixed within ...Honey bee invaders exploit the genetic resources of their predecessors
... The researchers were looking for tiny variations in the sequences of nucleotides that make up all genes. Certain versions of these single nucleotide polymorphisms (SNPs, or snips) are more common to African honey bees, while others occur more frequently in honey bees in western Europe, eastern ...Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
... for the treatment of certain cancers. Included within this restructuring were the decisions to discontinue further development of ANA380, a nucleotide analog for the treatment of hepatitis B virus (HBV) infection, halt all work on early discovery projects, and effect an immediate reduction ...Consortium publishes Phase II map of human genetic variation
... treat and prevent disease. The second-generation haplotype map, or Phase II HapMap, contains more than 3.1 million genetic variants, called single nucleotide polymorphisms (SNPs) three times more than the approximately 1 million SNPs contained in the initial version. The more SNPs that are on the map, the ...454 sequencing uncovers significant genetic variation
... appears online (ahead of print) today in the journal Science. Previous studies of human genomic variation tended to look at changes called single nucleotide polymorphism, variations that involve just one nucleotide, commonly referred to as SNP. However, the study published today suggests that structural ...SNPs Powerful Tools for Association Studies
... studies. This analysis will clarify why single nucleotide polymorphisms (SNPs) are powerful tools for ... from each other. In this case, the nucleotide change that results in a RFLP is also the ... change (i.e., an A-to-T change in the number two nucleotide of the sixth exon in the - globin chain of the ...Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A
... powerful tool for the identification of single nucleotide polymorphisms (SNPs). The frequency of ... 6-FAM-labeled probe, with the polymorphic nucleotide placed in the middle, hybridizes next ... Reverse: 5'-CACAGGGCAGGTCT-3' The third nucleotide position from the 3' end of the reverse primer ...RNA Interference and Gene Silencing: History and Overview
... PTGS indicate that these 21-23 nucleotide dsRNAs mediate PTGS. Introduction of siRNAs can ... embryo lysates was processed to 21-23 nucleotide species. They also found that the homologous ... and that cleavage occurred at 21-23 nucleotide intervals (26 ). ...Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA
... been shown to be mediated by 2123 nucleotide RNA fragments, termed short ... ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101(1) : 2533. ... is mediated by 21- and 22- nucleotide RNAs. Genes Dev. 15(2) : 188200. ...